English

Maravai LifeSciences Holdings, Inc.

EDGAR

MRVI Quarterly report (10-Q) · filed 2026-08-07

Annual consolidated revenue for 2025: about USD 185.7M, using the latest reported figures. The previous period, 2024, was about USD 259.2M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

51.4 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 51442000 USD Source

Operating margin

-29.33%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -15089000 USD Source
Revenue: 51442000 USD Source

Operating cash flow

3.99 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 12657000 USD Source
Operating Cash Flow: 8665000 USD Source

Free cash flow

3.62 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 12657000 USD Source
Operating Cash Flow: 8665000 USD Source
Capital Expenditure: 4807000 USD Source
Capital Expenditure: 4437000 USD Source

Cash and cash equivalents: 70.1 million USD 2026-06-30 Source
Exact value

70091000 USD
Long-term debt including current maturities: 147 million USD 2026-06-30 Source
Exact value

147105000 USD
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

209 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Revenue: 41630000 USD · 2025-07-01 – 2025-09-30 Source
Revenue: 185743000 USD · 2025-01-01 – 2025-12-31 Source
Revenue: 135877000 USD · 2025-01-01 – 2025-09-30 Source
Revenue: 65837000 USD · 2026-01-01 – 2026-03-31 Source
Revenue: 51442000 USD · 2026-04-01 – 2026-06-30 Source

Net income

-77.4 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -25556000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -130773000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -95092000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -3733000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -12416000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-25.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -34805000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -19655000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -57573000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -34805000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: 8665000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: 12657000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: 8665000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-07.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2025-12-31
Operating income: 7 of 11 periods available· newest 2025-12-31
Net income: 7 of 11 periods available· newest 2025-12-31
Operating cash flow: 7 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2025-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 6 of 11 periods available· newest 2025-12-31
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-28.3%

Prior period

USD 259.19 million

2024-01-01 – 2024-12-31
Current period

USD 185.74 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

185743000 − 259185000 = -73442000 USD

259185000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
185743000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Year-over-year change in Revenue: -73442000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 185743000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1514327 Filing: 000182323926000011 Input fundies:Revenue: 259185000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1526651 Filing: 000182323926000011
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 14.07 million

Prior period

−USD 144.85 million

2024-01-01 – 2024-12-31
Current period

−USD 130.77 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-130773000 − -144846000 = 14073000 USD

-144846000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-130773000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Year-over-year change in Net income: 14073000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -130773000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1212720 Filing: 000182323926000011 Input fundies:NetIncome: -144846000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1213572 Filing: 000182323926000011
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-871.2%

Prior period

USD 7.47 million

2024-01-01 – 2024-12-31
Current period

−USD 57.57 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-57573000 − 7465000 = -65038000 USD

7465000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-57573000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Year-over-year change in Operating cash flow: -65038000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -57573000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1407892 Filing: 000182323926000011 Input fundies:OperatingCashFlow: 7465000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1408543 Filing: 000182323926000011
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-55.7%

Prior period

USD 29.66 million

2024-01-01 – 2024-12-31
Current period

USD 13.15 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

13149000 − 29658000 = -16509000 USD

29658000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
13149000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Year-over-year change in Capital expenditure: -16509000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13149000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1412924 Filing: 000182323926000011 Input fundies:CapitalExpenditure: 29658000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1413515 Filing: 000182323926000011
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 185.74 million 100% of revenue
Cost of revenue USD 151.75 million 82% of revenue
Operating expenses USD 162.52 million 87% of revenue
Other operating costs Derived USD 86.74 million 47% of revenue
Operating income −USD 215.27 million −116% of revenue
Tax, interest and other Derived −USD 84.49 million −45% of revenue
Net income −USD 130.77 million −70% of revenue

Cash

Operating cash flow −USD 57.57 million −31% of revenue
Capital expenditure USD 13.15 million 7.1% of revenue
Free cash flow Derived −USD 70.72 million −38% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2019 Net loss: net income was −3.1% of revenue.
2020 31%11%58%
2021 23%47%31%
2022 25%40%35%
2023 Operating loss: operating costs were 111% of revenue.
2024 Operating loss: operating costs were 191% of revenue.
2025 Operating loss: operating costs were 216% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2019 2019-01-01 – 2019-12-31	143140000	119152000 Derived	23988000	28458000 Derived	-4470000	6967000 Derived	Source 2019-01-01 – 2019-12-31: 143140000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 23988000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -4470000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 24115000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 17148000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	284098000	164196000 Derived	119902000	30930000 Derived	88972000	126779000 Derived	Source 2020-01-01 – 2020-12-31: 284098000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 119902000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 88972000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 152187000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 25408000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	799240000	244595000 Derived	554645000	372608000 Derived	182037000	353720000 Derived	Source 2021-01-01 – 2021-12-31: 799240000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 554645000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 182037000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 368570000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 14850000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	883001000	308785000 Derived	574216000	354011000 Derived	220205000	518887000 Derived	Source 2022-01-01 – 2022-12-31: 883001000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 574216000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 220205000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 535977000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 17090000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	288945000	320593000 Derived	-31648000	87381000 Derived	-119029000	60671000 Derived	Source 2023-01-01 – 2023-12-31: 288945000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -31648000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -119029000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 126224000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 65553000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	259185000	494802000 Derived	-235617000	-90771000 Derived	-144846000	-22193000 Derived	Source 2024-01-01 – 2024-12-31: 259185000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -235617000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -144846000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 7465000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 29658000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	185743000	401009000 Derived	-215266000	-84493000 Derived	-130773000	-70722000 Derived	Source 2025-01-01 – 2025-12-31: 185743000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -215266000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -130773000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -57573000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 13149000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 185.7M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Revenue	143140000	Revenue: 143140000 Open source
20202020-12-31	Revenue	284098000	Revenue: 284098000 Open source
20212021-12-31	Revenue	799240000	Revenue: 799240000 Open source
20222022-12-31	Revenue	883001000	Revenue: 883001000 Open source
20232023-12-31	Revenue	288945000	Revenue: 288945000 Open source
20242024-12-31	Revenue	259185000	Revenue: 259185000 Open source
20252025-12-31	Revenue	185743000	Revenue: 185743000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-28.3% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Year over year	No prior comparable period	Revenue: 143140000 Open source
20202020-12-31	Year over year	98.5%	Revenue: 284098000 Open source Revenue: 143140000 Open source
20212021-12-31	Year over year	181.3%	Revenue: 799240000 Open source Revenue: 284098000 Open source
20222022-12-31	Year over year	10.5%	Revenue: 883001000 Open source Revenue: 799240000 Open source
20232023-12-31	Year over year	-67.3%	Revenue: 288945000 Open source Revenue: 883001000 Open source
20242024-12-31	Year over year	-10.3%	Revenue: 259185000 Open source Revenue: 288945000 Open source
20252025-12-31	Year over year	-28.3%	Revenue: 185743000 Open source Revenue: 259185000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -115.9% 2025

Net margin -70.4% 2025

Free cash flow margin -38.1% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20192019-12-31	Operating margin	16.8%	Operating Income: 23988000 Open source Revenue: 143140000 Open source
20202020-12-31	Operating margin	42.2%	Operating Income: 119902000 Open source Revenue: 284098000 Open source
20212021-12-31	Operating margin	69.4%	Operating Income: 554645000 Open source Revenue: 799240000 Open source
20222022-12-31	Operating margin	65%	Operating Income: 574216000 Open source Revenue: 883001000 Open source
20232023-12-31	Operating margin	-11%	Operating Income: -31648000 Open source Revenue: 288945000 Open source
20242024-12-31	Operating margin	-90.9%	Operating Income: -235617000 Open source Revenue: 259185000 Open source
20252025-12-31	Operating margin	-115.9%	Operating Income: -215266000 Open source Revenue: 185743000 Open source
20192019-12-31	Net margin	-3.1%	Net Income: -4470000 Open source Revenue: 143140000 Open source
20202020-12-31	Net margin	31.3%	Net Income: 88972000 Open source Revenue: 284098000 Open source
20212021-12-31	Net margin	22.8%	Net Income: 182037000 Open source Revenue: 799240000 Open source
20222022-12-31	Net margin	24.9%	Net Income: 220205000 Open source Revenue: 883001000 Open source
20232023-12-31	Net margin	-41.2%	Net Income: -119029000 Open source Revenue: 288945000 Open source
20242024-12-31	Net margin	-55.9%	Net Income: -144846000 Open source Revenue: 259185000 Open source
20252025-12-31	Net margin	-70.4%	Net Income: -130773000 Open source Revenue: 185743000 Open source
20192019-12-31	Free cash flow margin	4.9%	Revenue: 143140000 Open source Operating Cash Flow: 24115000 Open source Capital Expenditure: 17148000 Open source
20202020-12-31	Free cash flow margin	44.6%	Revenue: 284098000 Open source Operating Cash Flow: 152187000 Open source Capital Expenditure: 25408000 Open source
20212021-12-31	Free cash flow margin	44.3%	Revenue: 799240000 Open source Operating Cash Flow: 368570000 Open source Capital Expenditure: 14850000 Open source
20222022-12-31	Free cash flow margin	58.8%	Revenue: 883001000 Open source Operating Cash Flow: 535977000 Open source Capital Expenditure: 17090000 Open source
20232023-12-31	Free cash flow margin	21%	Revenue: 288945000 Open source Operating Cash Flow: 126224000 Open source Capital Expenditure: 65553000 Open source
20242024-12-31	Free cash flow margin	-8.6%	Revenue: 259185000 Open source Operating Cash Flow: 7465000 Open source Capital Expenditure: 29658000 Open source
20252025-12-31	Free cash flow margin	-38.1%	Revenue: 185743000 Open source Operating Cash Flow: -57573000 Open source Capital Expenditure: 13149000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -57.6M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Operating cash flow	24115000	Operating Cash Flow: 24115000 Open source
20202020-12-31	Operating cash flow	152187000	Operating Cash Flow: 152187000 Open source
20212021-12-31	Operating cash flow	368570000	Operating Cash Flow: 368570000 Open source
20222022-12-31	Operating cash flow	535977000	Operating Cash Flow: 535977000 Open source
20232023-12-31	Operating cash flow	126224000	Operating Cash Flow: 126224000 Open source
20242024-12-31	Operating cash flow	7465000	Operating Cash Flow: 7465000 Open source
20252025-12-31	Operating cash flow	-57573000	Operating Cash Flow: -57573000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -70.7M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20192019-12-31	Free cash flow	6967000	Operating Cash Flow: 24115000 Open source Capital Expenditure: 17148000 Open source
20202020-12-31	Free cash flow	126779000	Operating Cash Flow: 152187000 Open source Capital Expenditure: 25408000 Open source
20212021-12-31	Free cash flow	353720000	Operating Cash Flow: 368570000 Open source Capital Expenditure: 14850000 Open source
20222022-12-31	Free cash flow	518887000	Operating Cash Flow: 535977000 Open source Capital Expenditure: 17090000 Open source
20232023-12-31	Free cash flow	60671000	Operating Cash Flow: 126224000 Open source Capital Expenditure: 65553000 Open source
20242024-12-31	Free cash flow	-22193000	Operating Cash Flow: 7465000 Open source Capital Expenditure: 29658000 Open source
20252025-12-31	Free cash flow	-70722000	Operating Cash Flow: -57573000 Open source Capital Expenditure: 13149000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

51.6% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Liabilities / assets	Not reported	No source recorded
20202020-12-31	Liabilities / assets	87.8%	Total Liabilities: 1115945000 Open source Total Assets: 1270691000 Open source
20212021-12-31	Liabilities / assets	71.6%	Total Liabilities: 1372915000 Open source Total Assets: 1918276000 Open source
20222022-12-31	Liabilities / assets	60.3%	Total Liabilities: 1377072000 Open source Total Assets: 2282315000 Open source
20232023-12-31	Liabilities / assets	46.9%	Total Liabilities: 697566000 Open source Total Assets: 1487450000 Open source
20242024-12-31	Liabilities / assets	42.8%	Total Liabilities: 431035000 Open source Total Assets: 1008244000 Open source
20252025-12-31	Liabilities / assets	51.6%	Total Liabilities: 397866000 Open source Total Assets: 770577000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.6× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2019-12-31	Current assets / current liabilities	Not reported	No source recorded
20202020-12-31	Current assets / current liabilities	2.54×	Current Assets: 331598000 Open source Current Liabilities: 130778000 Open source
20212021-12-31	Current assets / current liabilities	7.89×	Current Assets: 740039000 Open source Current Liabilities: 93777000 Open source
20222022-12-31	Current assets / current liabilities	7.7×	Current Assets: 847902000 Open source Current Liabilities: 110144000 Open source
20232023-12-31	Current assets / current liabilities	8×	Current Assets: 699912000 Open source Current Liabilities: 87468000 Open source
20242024-12-31	Current assets / current liabilities	7.53×	Current Assets: 429146000 Open source Current Liabilities: 56971000 Open source
20252025-12-31	Current assets / current liabilities	6.6×	Current Assets: 296251000 Open source Current Liabilities: 44917000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2019 2019-01-01 – 2019-12-31	−USD 4.47 million Exact value Exact value: -4470000 USD 2019-01-01 – 2019-12-31: -4470000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Maravai LifeSciences Holdings, Inc. · 2019-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Net Income: -4470000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4470000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000012/mrvi-20211231.htm#1381039 Filing: 000182323922000012 The citation records this snapshot. The page link may show a newer release later.	USD 24.12 million Exact value Exact value: 24115000 USD 2019-01-01 – 2019-12-31: 24115000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Maravai LifeSciences Holdings, Inc. · 2019-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Operating Cash Flow: 24115000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24115000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000012/mrvi-20211231.htm#1764784 Filing: 000182323922000012 The citation records this snapshot. The page link may show a newer release later.	USD 17.15 million Exact value Exact value: 17148000 USD 2019-01-01 – 2019-12-31: 17148000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Maravai LifeSciences Holdings, Inc. · 2019-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Capital Expenditure: 17148000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17148000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000012/mrvi-20211231.htm#1771846 Filing: 000182323922000012 The citation records this snapshot. The page link may show a newer release later.	USD 6.97 million Calculation and evidence 24115000 − 17148000 USD Exact free cash flow: 6967000 USD 2019-01-01 – 2019-12-31: 24115000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 17148000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Maravai LifeSciences Holdings, Inc. · 2019-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Free cash flow: 6967000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24115000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000012/mrvi-20211231.htm#1764784 Filing: 000182323922000012 Input fundies:CapitalExpenditure: 17148000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323922000012/mrvi-20211231.htm#1771846 Filing: 000182323922000012 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 88.97 million Exact value Exact value: 88972000 USD 2020-01-01 – 2020-12-31: 88972000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Maravai LifeSciences Holdings, Inc. · 2020-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Net Income: 88972000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 88972000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000014/mrvi-20221231.htm#1372719 Filing: 000182323923000014 The citation records this snapshot. The page link may show a newer release later.	USD 152.19 million Exact value Exact value: 152187000 USD 2020-01-01 – 2020-12-31: 152187000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Maravai LifeSciences Holdings, Inc. · 2020-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Operating Cash Flow: 152187000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 152187000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000014/mrvi-20221231.htm#1777759 Filing: 000182323923000014 The citation records this snapshot. The page link may show a newer release later.	USD 25.41 million Exact value Exact value: 25408000 USD 2020-01-01 – 2020-12-31: 25408000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Maravai LifeSciences Holdings, Inc. · 2020-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Capital Expenditure: 25408000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25408000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000014/mrvi-20221231.htm#1784836 Filing: 000182323923000014 The citation records this snapshot. The page link may show a newer release later.	USD 126.78 million Calculation and evidence 152187000 − 25408000 USD Exact free cash flow: 126779000 USD 2020-01-01 – 2020-12-31: 152187000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 25408000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Maravai LifeSciences Holdings, Inc. · 2020-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Free cash flow: 126779000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 152187000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000014/mrvi-20221231.htm#1777759 Filing: 000182323923000014 Input fundies:CapitalExpenditure: 25408000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323923000014/mrvi-20221231.htm#1784836 Filing: 000182323923000014 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 182.04 million Exact value Exact value: 182037000 USD 2021-01-01 – 2021-12-31: 182037000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Maravai LifeSciences Holdings, Inc. · 2021-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Net Income: 182037000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 182037000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323924000032/mrvi-20231231.htm#1324777 Filing: 000182323924000032 The citation records this snapshot. The page link may show a newer release later.	USD 368.57 million Exact value Exact value: 368570000 USD 2021-01-01 – 2021-12-31: 368570000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Maravai LifeSciences Holdings, Inc. · 2021-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Operating Cash Flow: 368570000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 368570000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323924000032/mrvi-20231231.htm#1548781 Filing: 000182323924000032 The citation records this snapshot. The page link may show a newer release later.	USD 14.85 million Exact value Exact value: 14850000 USD 2021-01-01 – 2021-12-31: 14850000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Maravai LifeSciences Holdings, Inc. · 2021-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Capital Expenditure: 14850000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14850000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323924000032/mrvi-20231231.htm#1553496 Filing: 000182323924000032 The citation records this snapshot. The page link may show a newer release later.	USD 353.72 million Calculation and evidence 368570000 − 14850000 USD Exact free cash flow: 353720000 USD 2021-01-01 – 2021-12-31: 368570000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 14850000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Maravai LifeSciences Holdings, Inc. · 2021-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Free cash flow: 353720000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 368570000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323924000032/mrvi-20231231.htm#1548781 Filing: 000182323924000032 Input fundies:CapitalExpenditure: 14850000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323924000032/mrvi-20231231.htm#1553496 Filing: 000182323924000032 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 220.21 million Exact value Exact value: 220205000 USD 2022-01-01 – 2022-12-31: 220205000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Maravai LifeSciences Holdings, Inc. · 2022-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Net Income: 220205000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 220205000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000034/mrvi-20241231.htm#1310408 Filing: 000182323925000034 The citation records this snapshot. The page link may show a newer release later.	USD 535.98 million Exact value Exact value: 535977000 USD 2022-01-01 – 2022-12-31: 535977000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Maravai LifeSciences Holdings, Inc. · 2022-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Operating Cash Flow: 535977000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 535977000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000034/mrvi-20241231.htm#1495384 Filing: 000182323925000034 The citation records this snapshot. The page link may show a newer release later.	USD 17.09 million Exact value Exact value: 17090000 USD 2022-01-01 – 2022-12-31: 17090000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Maravai LifeSciences Holdings, Inc. · 2022-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Capital Expenditure: 17090000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17090000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000034/mrvi-20241231.htm#1502016 Filing: 000182323925000034 The citation records this snapshot. The page link may show a newer release later.	USD 518.89 million Calculation and evidence 535977000 − 17090000 USD Exact free cash flow: 518887000 USD 2022-01-01 – 2022-12-31: 535977000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 17090000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Maravai LifeSciences Holdings, Inc. · 2022-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Free cash flow: 518887000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 535977000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000034/mrvi-20241231.htm#1495384 Filing: 000182323925000034 Input fundies:CapitalExpenditure: 17090000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323925000034/mrvi-20241231.htm#1502016 Filing: 000182323925000034 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 119.03 million Exact value Exact value: -119029000 USD 2023-01-01 – 2023-12-31: -119029000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Maravai LifeSciences Holdings, Inc. · 2023-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Net Income: -119029000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -119029000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1214424 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	USD 126.22 million Exact value Exact value: 126224000 USD 2023-01-01 – 2023-12-31: 126224000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Maravai LifeSciences Holdings, Inc. · 2023-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Operating Cash Flow: 126224000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 126224000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1409189 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	USD 65.55 million Exact value Exact value: 65553000 USD 2023-01-01 – 2023-12-31: 65553000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Maravai LifeSciences Holdings, Inc. · 2023-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Capital Expenditure: 65553000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 65553000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1414106 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	USD 60.67 million Calculation and evidence 126224000 − 65553000 USD Exact free cash flow: 60671000 USD 2023-01-01 – 2023-12-31: 126224000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 65553000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Maravai LifeSciences Holdings, Inc. · 2023-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Free cash flow: 60671000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 126224000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1409189 Filing: 000182323926000011 Input fundies:CapitalExpenditure: 65553000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1414106 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 144.85 million Exact value Exact value: -144846000 USD 2024-01-01 – 2024-12-31: -144846000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Maravai LifeSciences Holdings, Inc. · 2024-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Net Income: -144846000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -144846000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1213572 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	USD 7.47 million Exact value Exact value: 7465000 USD 2024-01-01 – 2024-12-31: 7465000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Maravai LifeSciences Holdings, Inc. · 2024-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Operating Cash Flow: 7465000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7465000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1408543 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	USD 29.66 million Exact value Exact value: 29658000 USD 2024-01-01 – 2024-12-31: 29658000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Maravai LifeSciences Holdings, Inc. · 2024-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Capital Expenditure: 29658000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29658000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1413515 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	−USD 22.19 million Calculation and evidence 7465000 − 29658000 USD Exact free cash flow: -22193000 USD 2024-01-01 – 2024-12-31: 7465000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 29658000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Maravai LifeSciences Holdings, Inc. · 2024-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Free cash flow: -22193000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7465000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1408543 Filing: 000182323926000011 Input fundies:CapitalExpenditure: 29658000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1413515 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 130.77 million Exact value Exact value: -130773000 USD 2025-01-01 – 2025-12-31: -130773000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Net Income: -130773000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -130773000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1212720 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	−USD 57.57 million Exact value Exact value: -57573000 USD 2025-01-01 – 2025-12-31: -57573000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Operating Cash Flow: -57573000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -57573000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1407892 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	USD 13.15 million Exact value Exact value: 13149000 USD 2025-01-01 – 2025-12-31: 13149000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Capital Expenditure: 13149000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13149000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1412924 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.	−USD 70.72 million Calculation and evidence -57573000 − 13149000 USD Exact free cash flow: -70722000 USD 2025-01-01 – 2025-12-31: -57573000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 13149000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Maravai LifeSciences Holdings, Inc. · 2025-12-31 Maravai LifeSciences Holdings, Inc. (edgar:1823239) Free cash flow: -70722000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T18:00:12Z Snapshot: ab8290a3f9dd47be044d9fa8ee79c79438701908d54485ea43f91486d1b355d0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1823239?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -57573000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1407892 Filing: 000182323926000011 Input fundies:CapitalExpenditure: 13149000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1823239/000182323926000011/mrvi-20251231.htm#1412924 Filing: 000182323926000011 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

32 filings · 5,198 latest values · 5,198 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001823239, 1823239, MRVI, edgar:1823239

Also known as MARAVAI LIFESCIENCES HOLDINGS, INC., Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation